期刊
EXPERT OPINION ON THERAPEUTIC TARGETS
卷 12, 期 4, 页码 463-476出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.12.4.463
关键词
antisense oligonucleotides; apoptosis; cell cycle; dominant negative mutants; human cancers; inhibitor of apoptosis proteins; ribozymes; smail interfering RNAs; survivin
Background: Survivin is a structurally unique member of the inhibitor of protein (IAP) family that acts as a suppressor of apoptosis and plays a central role in cell division. Owing to its massive upregulation in human tumors and its involvement in cancer progression and treatment resistance, survivin is currently undergoing extensive investigation as a novel therapeutic target. Objective: The purpose of this review is to define potential of survivin as a therapeutic target for new anticancer interventions. Methods: The literature dealing with the therapeutic targeting of survivin has been carefully reviewed. Results/conclusion: Several preclinical studies have demonstrated that downregulation of survivin expression or function, accomplished by means of various strategies, reduced growth potential, increased the apoptotic rate and sensitized tumor cells to chemotherapeutic drugs and radiation in different human tumor models. Moreover, the first survivin inhibitors are being currently evaluated in clinical settings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据